Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly ...

Second quarter 2024 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session. Thursday July 25, 2024 14:30 - 16:00 CET ...

On November 19, 2018 Christophe Babule has been appointed Executive Vice-President, Chief Financial Officer and member of L'Oréal's Executive Committee as of mid-February 2019. Christophe Babule has ...

We want to build a healthier, more resilient world. We turn the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.

At Sanofi, we’re proud to be premium partner of Paris 2024. Like Olympians and Paralympians, we spend every day challenging ourselves and each other to be better, go further, and to never, ever settle ...

We chase the miracles of science to improve people’s lives, and sometimes that means starting over with Plan B, Plan C, or even Plan Z. This film brings together the inner thoughts and ambitions of ...

Nous sommes fiers d’être partenaire Premium des Jeux olympiques et paralympiques de Paris 2024. Comme les athlètes olympiques et paralympiques, nous nous mettons chaque jour au défi, individuellement ...

Sanofi has strong foundations in Canada going back over a century, and operates world-leading R&D and biomanufacturing facilities in Toronto. Sanofi also operates an artificial intelligence (AI) ...

Established in Australia in 1980, with a global heritage that spans 100 years, we invest in the health of Australians by pioneering science and medicine across therapeutic areas including immunology, ...

Il existe de meilleures solutions. De meilleurs médicaments, de meilleurs résultats, une meilleure science. Tout cela est dû à des personnes comme vous, issues de milieux différents, situées dans des ...

A Million Conversations is Sanofi’s global initiative to rebuild trust in healthcare with the underrepresented. Specifically with Black and ethnic minority groups, women, people with disabilities, and ...

Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Paris, France, and Houston, Texas, ...